Alcohol-associated liver disease
Open accessThe DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.
Abstract
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In ALD, hepatocyte cell death results in the release of DAMPs that, together with gut-derived PAMPs, activate surrounding immune cells and serve as recruiting signals for circulating immune cells [82, 83].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · cited 1×
“Alcohol-associated cirrhosis causes an estimated 25% of global deaths due to liver cirrhosis and up to 40% in certain areas of Europe (146).”
BackgroundMarrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539 · cited 1×
“Cirrhosis is a necessary intermediate step for A-HCC development and amplifies the overall risk for carcinogenesis in patients with ALD (157, 158).”
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“…liver disease, which encompasses all types of fatty liver diseases, now termed MASLD, which replaces the stig-matizing “nonalcoholic fatty liver disease” (NAFLD), and a new category, called MetALD, which includes patients with MASLD who also have significant alcohol consumption (143, 144).”
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 1×
“Indeed, by utilizing scRNA-Seq analysis, two studies have identified new cell subpopulations that drive fibrosis and inflammation in the mouse AH model and human alcohol-as-sociated cirrhosis (120, 121).”
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · cited 1×
“Moreover, alcohol misuse and ALD are associated with small intestinal bacterial overgrowth, alterations of gut microbiota (“dysbiosis”), and bacterial translocation (46, 47).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213 · cited 1×
“In 2010, we introduced binge ethanol intake into the chronically ethanol-fed mice, which causes significant neutrophil infiltration and liver injury (23, 133).”
Self-citation
Cited by
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 164
Self-citationShen, H., Zhou, L., Zhang, H., Yang, Y., Jiang, L., Wu, D., Shu, H., Zhang, H., Xie, L., Zhou, K., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.008 · Cited by 132
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Gao, H., Jiang, Y., Zeng, G., Huda, N., Thoudam, T., Yang, Z., Liangpunsakul, S., & Ma, J. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100104 · Cited by 87
Lai, W., Zhang, J., Sun, J., Min, T., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134809 · Cited by 111
Wang, W., Liu, M., Fu, X., Qi, M., Zhu, F., Fan, F., Wang, Y., Zhang, K., & Chu, S. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155814 · Cited by 75
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
Capone, F., Vacca, A., Bidault, G., Sarver, D. C., Kamińska, D., Strocchi, S., Vidal‐Puig, A., Greco, C. M., Lusis, A. J., & Schiattarella, G. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325492 · Cited by 81
Coordinated action of a gut–liver pathway drives alcohol detoxification and consumption
Fu, Y., Mackowiak, B., Lin, Y., Maccioni, L., Lehner, T., Pan, H., Guan, Y., Godlewski, G., Lu, H., Chen, C., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01063-2 · Cited by 71
Self-citationEpidemiology of liver diseases: global disease burden and forecasted research trends
Xiao, J., Wang, F., Yuan, Y., Gao, J., Lu, X., Chao, Y., Guo, F., Zhong, J., Che, Z., Li, W., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2722-2 · Cited by 74
Alcohol-associated liver cancer
Fu, Y., Maccioni, L., Wang, X. W., Greten, T. F., & Gao, B. (2024) · Hepatology · doi:10.1097/hep.0000000000000890 · Cited by 60
Self-citationInflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Feng, D., Hwang, S., Guillot, A., Wang, Y., Guan, Y., Chen, C., Maccioni, L., & Gao, B. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.04.009 · Cited by 44
Self-citationInflammation in MASLD progression and cancer
Kim, Y. S., Park, Y., Rho, H., Yao, T., Gao, B., & Hwang, S. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101414 · Cited by 75
“109 Furthermore, SCFAs promote autophagy by activating peroxisome proliferator-activated receptor (PPAR) c and uncoupling protein 2, thereby alleviating hepatic fat accumulation.”
Self-citationZhang, H., Hu, Q., Zhang, Y., Yang, L., Tian, S., Zhang, X., Shen, H., Shu, H., Xie, L., Wu, D., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2517821 · Cited by 48
Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes
Jamalinia, M., Lonardo, A., & Weiskirchen, R. (2024) · Fibrosis · doi:10.70322/fibrosis.2024.10006 · Cited by 50
Yan, W., Cheng, J., & Xu, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146997 · Cited by 40
“Thus, ALD can be slowed or reversed by blocking apoptosis [43].”
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 44
Metabolic dysfunction and alcohol-associated liver disease (MetALD)
Gao, B., Arab, J. P., Liangpunsakul, S., Ding, W., Szabó, G., Mehal, W. Z., Wang, H., He, Y., Stärkel, P., Llorente, C., et al. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100319 · Cited by 54
Self-citationDecoding organ fibrosis: mechanistic insights and emerging therapeutic strategies
Chen, X., Zhang, J., Guo, L., Wu, C., Zhou, J., Xu, M., Mo, L., Li, Y., & He, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02532-0 · Cited by 59
Hepatocellular carcinoma: pathogenesis, molecular mechanisms, and treatment advances
Ding, Z., Wang, L., Sun, J., Zheng, L., Tang, Y., & Tang, H. H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1526206 · Cited by 49
Ma, X., Niu, M., Ni, H., & Ding, W. (2026) · Hepatology · doi:10.1097/hep.0000000000000910 · Cited by 46
Apigenin as an emerging hepatoprotective agent: current status and future perspectives
Wang, C., Feng, X., Li, W., Chen, L., Wang, X., Lan, Y., Tang, R., Jiang, T., Zheng, L., & Liu, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1508060 · Cited by 42
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
Scarlata, G. G. M., Colaci, C., Scarcella, M., Dallio, M., Federico, A., Boccuto, L., & Abenavoli, L. (2024) · Diseases · doi:10.3390/diseases12040069 · Cited by 30
Exploring the association between air pollution and the incidence of liver cancers
Wu, X., Zhang, X., Yu, X., Liang, H., Tang, S., & Wang, Y. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117437 · Cited by 30
Lee, J., Jee, Y.-M., Yang, K., & Ryu, T. (2025) · Antioxidants · doi:10.3390/antiox14101196 · Cited by 42
Jaara, H. S., & Torres, S. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00062 · Cited by 36
Zhang, J., Zhong, J., Wang, W., Wang, S.-Y., Guo, X., Sun, H., & Song, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156638 · Cited by 29
The impact of aging on liver health and the development of liver diseases
Williams, S. N., & Ding, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000808 · Cited by 35
“It can further develop into more severe conditions such as steatohe-patitis, fibrosis, cirrhosis, and ultimately HCC. [108,109] The pathogenesis of alcohol-induced liver injury involves disrupting numerous physiological processes in the liver.”
Koizumi, A., Kaji, K., Nishimura, N., Asada, S., Matsuda, T., Tanaka, M., Yorioka, N., Tsuji, Y., Kitagawa, K., Sato, S., et al. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i28.3428 · Cited by 28
Wang, Y., Guan, Y., Feng, D., Maccioni, L., Parra, M. A., Peiffer, B., Mackowiak, B., Kuwabara, T., Mori, K., Mukoyama, M., et al. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01343-1 · Cited by 23
Self-citationAn Update on Animal Models of Alcohol-Associated Liver Disease
Cao, P., Chao, X., Ni, H., & Ding, W. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.11.011 · Cited by 31
Chen, P., Zou, F., & Liu, W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1549526 · Cited by 39
“Consequently, GA plays a critical role in the prevention of HCC by ameliorating liver injury and exerting its anti-tumor property.”
InfluentialMaccioni, L., Guan, Y., Kim, M., Parra, M. A., Peiffer, B., Fu, Y., Wang, Y., Lin, Y.-H., Mackowiak, B., Feng, D., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334412 · Cited by 21
“1 In addition, the liver is an organ with prevalent innate immunity 15 that plays an important role in ALD pathogenesis.”
Self-citationNew therapeutic target for alcohol-associated hepatitis (AH): AH-associated IL-8+ neutrophils
Guan, Y., Feng, D., Maccioni, L., Wang, Y., & Gao, B. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100166 · Cited by 21
Self-citationEngineering Mice to Study Human Immunity
Sefik, E., Xiao, T., Chiorazzi, M., Odell, I. D., Zhang, F., Agrawal, K., Micevic, G., & Flavell, R. A. (2025) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082523-124415 · Cited by 25
Steatotic liver disease and cancer: from pathogenesis to therapeutic targets
Yang, Z., Liu, Z., Liu, W., & Dong, X. C. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100218 · Cited by 33
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression
Osna, N. A., Tikhanovich, I., Ortega‐Ribera, M., Mueller, S., Zheng, C., Mueller, J. H., Li, S., Sakane, S., Weber, R. C. G., Kim, H. Y., et al. (2024) · Biomolecules · doi:10.3390/biom14040404 · Cited by 28
“…from other organs to the liver, the disruption of mitochondrial fatty acid β -oxidation, and sustained changes in the induction/expression of transcription factors associated with hepatic lipid metabolism, the cumulative effect of which is to elevate intracellular (hepatocyte) lipid content [185].”
BackgroundRoles of Cellular Neighborhoods in Hepatocellular Carcinoma Pathogenesis
Ma, L., Li, C., & Wang, X. W. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023520 · Cited by 24
Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases
Perumal, S. K., Arumugam, M. K., Osna, N. A., Rasineni, K., & Kharbanda, K. K. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1478542 · Cited by 23
“While ethanol metabolism in the gastrointestinal tract locally generates low levels of acetaldehyde and other toxic metabolites, the liver is the primary organ that carries out ethanol metabolism and consequently sustains the greatest organ damage from heavy drinking (41, 42).”
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer
Liu, T., Zhang, F., Feng, Y., Han, P., & Gao, Y. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-3320 · Cited by 31
“4,52 Notably, gut-derived ethanol (e.g., from high ethanol-producing Klebsiella pneumoniae strains) induces intestinal barrier damage and hepaticin fl ammationviamechanismsanalogoustoexogenous ethanol.”
Liver and obesity: a narrative review
Lonardo, A., & Weiskirchen, R. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001334 · Cited by 23
Shen, H., Zhou, L., Yang, Y., Shu, H., Wu, D., Yang, S., Xie, L., Yang, L., Tian, S., Zhang, X., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000599 · Cited by 23
“[1] Current treatments for ALD are limited and largely ineffective, [2] primarily due to the complex pathogenesis of the disease, which involves intricate interaction between genetics, the immune system, gut microbiota, and environmental factors.”
Role of cellular senescence in hepatic diseases (Review)
Xing, Y., & Zhu, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5623 · Cited by 21
Liver disease trends in the Asia-Pacific region for the next 50 years
Shiina, S., Maikhuu, J., Qing, D., Batsaikhan, T., Canseco, L. M., Tobari, M., Maruyama, H., Nagamatsu, H., Alcantara‐Payawal, D., Gani, R. A., et al. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0043 · Cited by 19
Xie, Y., Tao, M., Yan, X., Fan, X., Bayoude, A., Lu, Y., Zhao, S., Yu, B., & Li, R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143145 · Cited by 17
Jiang, X., Wang, H., Nie, K., Gao, Y., Shen, C., Tang, Y., Wang, Z., Su, H., & Dong, H. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00988-w · Cited by 17
Addissouky, T. A. (2024) · Discover Medicine · doi:10.1007/s44337-024-00083-x · Cited by 16
Xu, H., Wu, Z., Qin, J., Li, X., Xu, F., Wang, W., Zhang, H., Yin, H., Zhu, S., Zhang, W., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334318 · Cited by 15
Dou, J.-Y., Liu, S.-H., Guo, J., Wang, C., Dai, X., Lian, L., Cui, Z., Nan, J., & Wu, Y. (2024) · Food & Function · doi:10.1039/d4fo03898c · Cited by 15
Myeloid cells in chronic liver inflammation
Patseas, D., El-Masry, A., Liu, Z., Ramachandran, P., & Triantafyllou, E. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01324-4 · Cited by 22
Yi, Y., Yan, Y., Zhan, G., Deng, W., Wei, Y., Zhang, Y., Gao, J., & Gong, Q. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c04131 · Cited by 14
Khazaei, M., & Ardeshir, R. A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117715 · Cited by 15
Jiang, Y. Z., Wei, S., Shen, S., Liu, Y., Su, W., Ding, D., Zheng, Z., Yu, H., Zhang, T., Yang, Q., et al. (2024) · Advanced Science · doi:10.1002/advs.202409516 · Cited by 19
Zhou, H., Huang, Y., Chen, C., Song, M., & Hylemon, P. B. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100120 · Cited by 19
Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils
Wang, J., Wang, X., Peng, H., Dong, Z., Liangpunsakul, S., Zuo, L., & Wang, H. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.03.001 · Cited by 15
Radosavljević, T. S., Branković, M., Djuretić, J., Grujić-Milanović, J. D., Kovačić, M. V., Jevtić, J., Stankovic, S. D., Samardžić, J., Vučević, D. B., & Jakovljevic, V. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010086 · Cited by 16
Ai, R., Tian, M., Sun, J., He, S., Cui, Z., Yang, Y., Hou, X., Zhao, Y., Dou, T., Chen, X., et al. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151912 · Cited by 13
Tadokoro, T., Oura, K., Nakahara, M., Fujita, K., Tani, J., Morishita, A., & Kobara, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178328 · Cited by 20
“Only 35% of heavy drinkers develop advanced ALD, suggesting the involvement of additional contributing factors [6,7].”
Ogawa, T., Sato, T., Tanaka, M., Akiyama, Y., Nakata, K., Kouzu, H., Mori, K., Aida, H., Kawaharata, W., Hosaka, I., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-25-0019 · Cited by 19
Food insecurity is an emerging risk factor for liver disease: a scoping review
Lonardo, A., Zheng, M., & Weiskirchen, R. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2545812 · Cited by 16
Bai, T., Guo, H., Wang, F., Kang, Y.-Y., Zhang, H., Dong, L., & Yang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1532590 · Cited by 14
“Alcoholic liver fi brosis (ALF) is developed from simple hepatic steatosis and steatohepatitis induced by alcohol consumption, which can further progress into cirrhosis and even hepatocellular carcinoma, posing a serious threat to human health (Mackowiak et al., 2024).”
Huang, J., Yu, L., Zhang, C., Fang, Y., Zhou, X., Wang, R., Xing, L., Wang, L., Yu, N., Peng, D., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148202 · Cited by 17
Xu, C. Q., Ali, M., Sun, J., Li, X., Fouad, D., Iqbal, M., Kulyar, M. F., Wu, Y., & Li, K. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116495 · Cited by 12
Luo, Q., Qiu, J., Chen, M., Yang, N., Li, X., Huang, S., Ma, Q., Li, Z., Lou, D., Du, Y., et al. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116321 · Cited by 14
Zhu, Y., Jia, Y., & Zhang, E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1516603 · Cited by 19
“The development of ALD is multifaceted, shaped by complex interactions among genetic, environmental, and metabolic factors (Mackowiak et al., 2024; Malnick et al., 2022).”
The Link between Alcohol Consumption and Kidney Injury
Yokus, B., Maccioni, L., Fu, L., Haskó, G., Nagy, L. E., Gao, B., & Pacher, P. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.011 · Cited by 21
Self-citationHayat, M. S., Shoaib, M. M., Sohail, S., Ahmed, S., Shahid, F., Ahmad, H., Naseer, M. R., Shoaib, M. M., & Ahmed, R. (2025) · Medicine · doi:10.1097/md.0000000000041988 · Cited by 11
Zsuzsa, M., Jenei, V., Mácsik, R., Mezhonova, E., Diyab, S., Csősz, R., Bácsi, A., Mázló, A., & Koncz, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07563-7 · Cited by 17
Qi, Y., Fang, Q., Chen, Z., Chen, L., & Du, J. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.111290 · Cited by 14
Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease
Ding, Q., Cao, F., Zhuge, H., Lai, S., Cao, W., Wei, H., Guo, R., Qiu, J., Song, Q., Pei, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt6195 · Cited by 12
Wu, K., Zhao, L., Yang, J., Yang, J., Zhao, Y., Du, F., Chen, Y., Deng, S., Shen, J., Xiao, Z., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120465 · Cited by 14
The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential
Li, L., Li, X., & Zhang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1694582 · Cited by 15
“…to secrete CKs, in turn triggering the in fl ammatory cells to recruit to liver and increasing micro ribonucleic acid (miRNA)-155 expression through NF-k B pathway, then stimulating the lipopolysaccharids-triggered KCs to secrete TNF, ultimately facilitating liver in fl ammation (164, 165).”
Liver injury protection of Artemisia stechmanniana besser through PI3K/AKT pathway
Tian, C.-B., Qin, M.-L., Qian, Y.-L., Qin, S.-S., Shi, Z.-Q., Zhao, Y., & Luo, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118590 · Cited by 10
Guo, X., Liu, C., Dong, Z., Luo, G., Li, Q., & Huang, M. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156215 · Cited by 10
Gut cannabinoid receptor 1 regulates alcohol binge-induced intestinal permeability
Maccioni, L., Dvorácskó, S., Godlewski, G., Çınar, R., Iyer, M. R., Gao, B., & Kunos, G. (2025) · eGastroenterology · doi:10.1136/egastro-2024-100173 · Cited by 12
Self-citationDeep Learning Reveals Liver MRI Features Associated With PNPLA3 I148M in Steatotic Liver Disease
Chen, Y., Laevens, B. P. M., Lemainque, T., Müller‐Franzes, G. A., Seibel, T., Dlugosch, C., Clusmann, J., Koop, P., Gong, R., Liu, Y., et al. (2025) · Liver International · doi:10.1111/liv.70164 · Cited by 11
Maćków, M., Dziubyna, T., Jamer, T., Slivinskyi, D., Pytrus, T., Neubauer, K., Zwolinska-Wcislo, M. M., Stawarski, A., Piotrowska, E., & Nowacki, D. (2024) · Nutrients · doi:10.3390/nu16203505 · Cited by 13
“It was suggested that excessive T-lymphocyte production plays an important role in the development of steatohepatitis associated with MASLD [21].”
BackgroundSingle‐cell landscape of the intrahepatic ecosystem in alcohol‐related liver disease
Zhao, X., Wang, S., Liu, Q., Wei, W., Sun, X., Song, H., Xu, J., Zhang, S., Wang, H., & Fu, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70198 · Cited by 11
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and Beyond
Fu, L., Yokus, B., Gao, B., & Pacher, P. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.03.010 · Cited by 12
Self-citationLi, S., Fu, Y., Jia, X., Liu, Z., Qian, Z., Zha, H., Lei, G., Yu, L., Zhang, X., Zhang, T., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-334448 · Cited by 14
Self-citationLiu, L., Qian, S., Li, W., Dong, S., Ya, R., He, Y., Huang, H., Chen, Y., Ma, N., Hao, Y., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.022 · Cited by 9
Macrophages in necrotic liver lesion repair: opportunities for therapeutical applications
Wang, Y., Rodrigues, R. M., Chen, C., Feng, D., Maccioni, L., & Gao, B. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00053.2024 · Cited by 11
Self-citationTang, M., Zhao, L., Huang, F., Wang, T., Wu, X., Chen, S., Fu, J., Jiang, C., Wei, S., Zeng, X., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1495695 · Cited by 8
“Specifically, alcohol exposure boosts the activity of the hepatic CYP2E1 enzyme, which increases ROS production, causing hepatic mitochondrial dysfunction, and stimulates de novo lipogenesis (28).”
InfluentialWei, S., Li, M., Zhao, L., Wang, T., Wu, K., Yang, J., Liu, Y., Zhao, Y., Du, F., Chen, Y., et al. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01049-y · Cited by 8
The Ways to Die: Cell Death in Liver Pathophysiology
Cao, P., Jaeschke, H., Ni, H., & Ding, W. (2025) · Seminars in Liver Disease · doi:10.1055/a-2576-4332 · Cited by 12
Yao, J., Liu, P., Teng, X., Kong, D., Han, B., Cui, C., Yin, M., Yan, X., Zhao, A., Ye, Y., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001374 · Cited by 14
Zhang, B., Liu, M., Jiang, L., Chen, Z., Tian, W., Li, K., Yu, B., Zhang, W., Li, S., Zhou, Y., et al. (2025) · Current Microbiology · doi:10.1007/s00284-025-04474-w · Cited by 8
Lonardo, A., & Suzuki, A. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.1005101 · Cited by 10
Kan, M., Wang, R., Chen, L., Lv, X., Qiu, W., Zhang, H., Zhao, J., Li, M., Wen, X., Meng, X., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.006 · Cited by 9
Liu, C., Wang, Y., Sheng, L., Zhang, Y., Luo, G., Ruan, X. Z., Chen, Y., & Huang, M. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156445 · Cited by 9
Tang, Y., Zhou, H., Pan, X., Zhong, Z., Liu, H., & Guo, Y. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156175 · Cited by 9
Cao, Y.-J., Yang, Y., Liang, Z., Guo, W., Lv, X., Ni, L., & Chen, Y. (2024) · Foods · doi:10.3390/foods13172760 · Cited by 7
“Drug therapy is the primary treatment for patients with ALD, but there are no completely effective drugs for the treatment of ALD [5,6].”
BackgroundLi, Y., Ye, Z., Ran, X., Luo, J., Li, H. Z., Zhou, P., Shen, S., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-78890-6 · Cited by 17
Hu, W., Naimi, S., Trainel, N., Moal, V. L.-L., Perlemuter, G., Chassaing, B., Ciocan, D. M., & Cassard, A. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00602-9 · Cited by 7
Srinivasan, M. P., Kota, S., Bhopale, K. K., Caracheo, A. A., Kaphalia, L., Linares, J., Romsdahl, T. B., Russell, W. K., Popov, V. L., Boor, P., et al. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2024 · Cited by 8
NLRP3 and Gut–Liver Axis: New Possibility for the Treatment of Alcohol‐Associated Liver Disease
Dong, L., Zhang, H., Kang, Y., Wang, F., Bai, T., & Yang, Y. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16935 · Cited by 7
Ding, K., Mao, A., Wang, Y., Ni, Z., Shi, Y., Liu, K., Zhang, J., Zheng, W., Liu, L., Liu, Q., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.11.008 · Cited by 8
Role of immune cell interactions in alcohol-associated liver diseases
Wang, X., Wang, J., Peng, H., Zuo, L., & Wang, H. (2024) · Liver Research · doi:10.1016/j.livres.2024.06.002 · Cited by 11
“71 3.2.”
InfluentialZeng, L., Zhu, L., Fu, S., Li, Y., & Hu, K. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05144-4 · Cited by 11
Hepatic microRNA-320 restrains ferroptosis to mitigate acute-on-chronic alcohol-induced liver injury
Li, W., Liu, L., Qian, S., Chen, Y., Ya, R., Ma, N., Hao, Y., Ge, S., Zhang, X., Liu, Y., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167748 · Cited by 8
Metadata
- Authors
- Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gao, Bin
- Venue
- Journal of Clinical Investigation
- Published
- 2024-02-01
- Volume
- 134
- Issue
- 3
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10836812
- OpenAlex
- W4391540982
- Cited by
- 359
- References
- 202
- Citations by year
- 2026: 129 · 2025: 160 · 2024: 70
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- alcoholic liver disease, alcoholic steatohepatitis, alcoholic cirrhosis, pathogenesis, therapeutic target, multi-omics, preclinical models, metabolic dysfunction, disease heterogeneity, translational research
- MeSH terms
- Ethanol, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.